COVID-19 - April 28, 2021
Bio-Me part of a study of the long-term effects of COVID-19
Akershus University Hospital (Ahus) and Bio-Me are collaborating in a study of the long-term effects of COVID-19 in adolescents and young adults (LoTECA). The study will investigate the involvement of the microbiome in such long-term effects. Based on several international studies, it is possible that the intestinal microbiota could be disturbed for a long time […]
COVID-19 - April 19, 2021
Pfizer/BioNTech to supply the EU with 100 million additional vaccine doses
Pfizer and BioNTech have announced they will supply an additional 100 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced […]
COVID-19 - April 19, 2021
New research project on Nordic health data
A new Nordic research project will make use of Nordic health data to study pandemics from a historical perspective. In December 2020, NordForsk awarded funding to 12 new interdisciplinary research projects in collaboration with: the Independent Research Fund Denmark; Formas of Sweden; the Swedish Research Council; the Icelandic Centre for Research – Rannís; the Swedish […]
COVID-19 - April 14, 2021
Johnson & Johnson’s vaccine temporarily paused
The company delays EU vaccine deliveries as US pauses use over blood clots. Johnson & Johnson is to pause deliveries of its single-shot COVID-19 vaccine in Europe pending an investigation of rare blood clot cases that have halted rollout in the US, it announced. “We have been reviewing these cases with European health authorities,” the […]
COVID-19 - April 9, 2021
One in 10 have long-term effects 8 months after mild COVID-19
The most common long-term symptoms are a loss of smell and taste and fatigue, according to a study published in the journal JAMA, conducted by researchers at Danderyd Hospital and Karolinska Institutet. “We investigated the presence of long-term symptoms after mild COVID-19 in a relatively young and healthy group of working individuals, and we found […]
COVID-19 - April 8, 2021
Possible link between AstraZeneca’s vaccine and rare blood clots, states EMA
The European Medicines Agency’s safety committee (PRAC) has concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group, it states […]
